Four weeks after cell inoculations, we found that overexpressing MFSD4A-AS1 dramatically increased the number of tumor cells in lymph nodes from the MFSD4A-AS1-overexpressing mice group compared with that in vector mice group (Fig. 2B and C). This evidence concerns the gene SLC60A1 and neoplasm.